Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)

Summary

This is a prospective, randomized, double-blinded, placebo-controlled, pilot study to assess the preliminary efficacy and safety of hydroxychloroquine for the treatment of patients with lower respiratory tract SARS-CoV-2 infection.

Timeline

Start

2020-08

Primary completion

2021-03

Completion

2021-09

Drugs

Indications